Biotech RadarJobs updated

COMPANY

Oncovir

oncovir.com ↗

Clinical Phase 1

Keywords: vaccine oncology infectious disease infectious diseases Malignant Pleural Mesothelioma COVID - 19 Melanoma Head and Neck Cancer Sarcoma Non-Melanoma Skin Cancers Hiltonol

Profile checked Oct 10, 2026

4Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults source ↗
  2. Trial start Phase 1: Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma source ↗
  3. Trial start Phase 1/Phase 2: Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 source ↗
  4. Trial start Phase 2: In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® source ↗

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT04525859Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural MesotheliomaPhase 1CompletedAug 19, 2020Jun 18, 2025 (actual)
NCT04672291Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated AdultsPhase 1CompletedJul 21, 2021Apr 1, 2023 (actual)
NCT03721679Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1Phase 1/Phase 2TerminatedSep 25, 2018Jan 26, 2021 (actual)
NCT02423863In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®Phase 2Completed2015-03Aug 31, 2020 (actual)
Feedback